#addiction#treatment#AUD#FDA#University of North Carolina (UNC)Chapel Hill School of Medicine Semaglutide shows promise in treating alcohol addiction Federal funding for public health and clinical trials is essential in advancing innovative treatments for addiction, as demonstrated by recent research on Semaglutide, which shows promise in reducing alcohol cravings and consumption
Although this difference approached but did not reach the threshold for clinical significance established in other studies, 134 the findings suggest the potential neuroprotective effects of lixisenatide, possibly mediated by increased synaptic dopamine levels, as supported by preclinical and clinical research in addictive disorders
Most studies have reported that GLP-1RAs have renoprotective effects
In conclusion, obesity and the highly related incidence of diabetes are tremendous societal health problems that are preventable and treatable
Bottom line Insomnia isnt considered a common side effect of Wegovy, and clinical data doesnt list it as a major adverse effect
